SINGLE CHAMBER LEADLESS INTRA-CARDIAC MEDICAL DEVICE HAVING DUAL CHAMBER SENSING WITH SIGNAL DISCRIMINATION

• US 20130138006A1
• Filed: 05/31/2012
• Published: 05/30/2013
• Est. Priority Date: 11/04/2011
• Status: Abandoned Application

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Bornzin, Gene A., Min, Xiaoyi, Poore, John W., Somogyi, Zoltan
• Application Number:
  US13/485,534
• Publication Number:
  US 20130138006A1
• Time in Patent Office: Days
• US Class Current: 600/509
• CPC Class Codes: A61B 5/283 Invasive
• CPC Class Codes: A61B 5/6869 Heart
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators

Abstract

A leadless intra-cardiac medical device (LIMD) includes multiple electrodes that allow for stimulation and sensing of the right ventricle (RV) and sensing of the right atrium (RA), even though it is entirely located in the RV. The LIMD includes a housing having a proximal end configured to engage local tissue in the local chamber and electrodes located at multiple locations along the housing. Sensing circuitry is configured to define a far field (FF) channel between a first combination of the electrodes to sense FF signals occurring in the adjacent chamber. The sensing circuitry is configured to define a near field (NF) channel between a second combination of the electrodes to sense NF signals occurring in the local chamber. A controller is configured to analyze the NF and FF signals to determine whether the NF and FF signals collectively indicate that a validated event of interest occurred in the adjacent chamber.

Claims

1. A leadless intra-cardiac medical device (LIMD) configured to be implanted entirely within a single local chamber of the heart and remote from an adjacent chamber of the heart, the LIMD comprising:

a housing having a proximal end configured to engage local tissue of interest in the local chamber and a distal end;

electrodes located at multiple locations along the housing;

sensing circuitry configured to define a far field (FF) channel between a first combination of the electrodes to sense FF signals;

the sensing circuitry configured to define a near field (NF) channel between a second combination of the electrodes to sense NF signals; and

a controller configured to analyze the NF and FF signals to determine whether the NF and FF signals collectively indicate that a validated event of interest occurred in the adjacent chamber.

2. The LIMD of claim 1, wherein the electrodes include a proximal electrode located at the proximal end, a distal electrode located at the distal end, and an intermediate electrode located at an intermediate region along the housing.

3. The LIMD of claim 2, wherein the first electrode combination comprises the distal electrode and the intermediate electrode.

4. The LIMD of claim 2, wherein the second electrode combination comprises the proximal electrode and the intermediate electrode.

5. The LIMD of claim 2, wherein the proximal and intermediate electrodes are separated by a first inter-electrode (IE) spacing, the distal and intermediate electrodes are separated by a second IE spacing, and the second IE spacing is greater than the first IE spacing.

6. The LIMD of claim 1, wherein the controller is configured to compare the FF signals sensed over the FF channel to a FF adjacent-chamber criteria, compare the NF signals sensed over the NF channel to a NF adjacent-chamber criteria, and declare a validated event when both of the criteria are satisfied.

7. The LIMD of claim 6, wherein the FF adjacent-chamber criteria is a FF signal amplitude threshold, the NF adjacent-chamber criteria is a NF signal amplitude threshold and the criteria is satisfied when the amplitude of the sensed FF signals exceeds the FF signal amplitude threshold and the amplitude of the sensed NF signals does not exceed the NF signal amplitude threshold.

8. The LIMD of claim 6, wherein the FF adjacent-chamber criteria is a FF signal morphology, the NF adjacent-chamber criteria is a NF signal morphology, and the criteria is satisfied when the morphology of the sensed FF signals matches the FF signal morphology and the morphology of the sensed NF signals matches the NF signal morphology.

9. The LIMD of claim 6, wherein the FF adjacent-chamber criteria is a FF signal amplitude range, the NF adjacent-chamber criteria is a NF signal amplitude threshold, and the criteria is satisfied when the amplitude of the sensed FF signals is within the FF signal amplitude range and the amplitude of the sensed NF signals does not exceed the NF signal amplitude threshold.

10. The LIMD of claim 1, wherein the controller is further configured to analyze the NF and FF signals to determine whether the NF and FF signals collectively indicate that a validated event of interest occurred in the local chamber.

11. The LIMD of claim 10, wherein the controller is configured to compare the FF signals sensed over the FF channel to a FF local-chamber criteria, compare the NF signals sensed over the NF channel to a NF local-chamber criteria, and declare a validated event when both of the criteria are satisfied.

12. The LIMD of claim 11, wherein the FF local-chamber criteria is a FF signal amplitude threshold, the NF local-chamber criteria is a NF signal amplitude threshold, and the criteria is satisfied when the amplitude of the sensed FF signals exceeds the FF signal amplitude threshold and the amplitude of the sensed NF signals exceeds the NF signal amplitude threshold.

13. The LIMD of claim 11, wherein the FF local-chamber criteria is a FF signal morphology, the NF local chamber criteria is a NF signal morphology, and the criteria is satisfied when the morphology of the sensed FF signals matches the FF signal morphology and the morphology of the sensed NF signals match the NF signal morphology.

15. The method of claim 11, wherein analyzing comprises:

comparing the FF signals sensed over the FF channel to a FF adjacent-chamber criteria;

comparing the NF signals sensed over the NF channel to a NF adjacent-chamber criteria; and

declaring a validated event when both of the criteria are satisfied.

16. The method of claim 15, wherein the FF adjacent-chamber criteria is a FF signal amplitude threshold, the NF adjacent-chamber criteria is a NF signal amplitude threshold, and the criteria is satisfied when the amplitude of the sensed FF signals exceeds the FF signal amplitude threshold and the amplitude of the sensed NF signals does not exceed the NF signal amplitude threshold.

17. The method of claim 15, wherein the FF adjacent-chamber criteria is a FF signal morphology, the NF adjacent-chamber criteria is a NF signal morphology, and the criteria is satisfied when the morphology of the sensed FF signals matches the FF signal morphology and the morphology of the sensed NF signals matches the NF signal morphology.

18. The method of claim 15, wherein the FF adjacent-chamber criteria is a FF signal amplitude range, the NF adjacent-chamber criteria is a NF signal amplitude threshold, and the criteria is satisfied when the amplitude of the sensed FF signals is within the FF signal amplitude range and the amplitude of the sensed NF signals does not exceed the NF signal amplitude threshold.

19. The method of claim 11, further comprising analyzing the NF and FF signals to determine whether the NF and FF signals collectively indicate that a validated event of interest occurred in the local chamber.

20. The method of claim 19, wherein analyzing comprises:

comparing the FF signals sensed over the FF channel to a FF local-chamber criteria;

comparing the NF signals sensed over the NF channel to a NF local-chamber criteria; and

declaring a validated event when both of the criteria are satisfied.

21. The method of claim 20, wherein the FF local-chamber criteria is a FF signal amplitude threshold, the NF local-chamber criteria is a NF signal amplitude threshold, and the criteria is satisfied when the amplitude of the sensed FF signals exceeds the FF signal amplitude threshold and the amplitude of the sensed NF signals exceeds the NF signal amplitude threshold.

22. The method of claim 20, wherein the FF local-chamber criteria is a FF signal morphology, the NF local chamber criteria is a NF signal morphology, and the criteria is satisfied when the morphology of the sensed FF signals matches the FF signal morphology and the morphology of the sensed NF signals matches the NF signal morphology.

14. A method for sensing cardiac activity from a leadless intra-cardiac medical device (LIMD) configured to be implanted entirely within a single local chamber of the heart and remote from an adjacent chamber, the method comprising:

sensing far field (FF) signals over a FF channel between a first combination of electrodes provided on the LIMD in the local chamber;

sensing near field (NF) signals over a NF channel between a second combination of electrodes provided on the LIMD in the local chamber; and

analyzing both of the NF and FF signals to determine whether the NF and FF signals indicate that a validated event of interest occurred in the adjacent chamber.